跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 11,160 条关于
“R/M HNSCC”
全部
11,160
临床试验
3,984
药物
1,967
机构
415
资讯
4,794
9天前
Pyxis Oncology's MICVO Posts 36% Confirmed ORR and 79% 12-Month OS Probability in 2L+ R/M Head and Neck Cancer
去年
Akeso's Phase 3 Trial Begins for Ivonescimab and Ligufalimab Combination in Head and Neck Cancer
去年
FDA Grants Fast Track Status to Pyxis Oncology's PYX-201 for Advanced Head and Neck Cancer
11个月前
Subcutaneous Amivantamab Shows 45% Response Rate in Recurrent Head and Neck Cancer
9个月前
Pyxis Oncology Reports Promising Phase 1 Results for Novel ADC MICVO in Head and Neck Cancer
去年
Merus Doses First Patient in Phase 3 Trial of Petosemtamab for Head and Neck Cancer
去年
FDA Grants Second Breakthrough Therapy Designation for Petosemtamab in Head and Neck Cancer
7个月前
Pyxis Oncology Appoints Thomas Civik as Interim CEO to Advance MICVO Cancer Therapy Development
去年
Cue Biopharma's CUE-101 and CUE-102 Show Promising Phase 1 Results in Cancer Trials
2年前
PDS Biotech's Versamune HPV Plus Keytruda Shows Promising Results in HPV16-Positive Head and Neck Cancer
第 1 页,共 480 页
上一页
下一页